Cost-Effectiveness of Prostate Radiation Therapy in Men with Newly Diagnosed Low Burden Metastatic Prostate Cancer

被引：0
|
作者：
Lester-Coll, N. H. [1 ]
Ades, S. [2 ]
Yu, J. B. [3 ]
Atherly, A. [4 ]
Wallace, H. J. [1 ]
Sprague, B. L. [5 ]
机构：
[1] Univ Vermont, Larner Coll Med, Div Radiat Oncol, Burlington, VT USA
[2] Univ Vermont, Larner Coll Med, Div Hematol & Oncol, Burlington, VT USA
[3] Yale Sch Med, Dept Therapeut Radiol, New Haven, CT USA
[4] Univ Vermont, Dept Med, Larner Coll Med, Burlington, VT USA
[5] Univ Vermont, Dept Surg, Larner Coll Med, Burlington, VT 05405 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.221
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1141
引用
收藏
页码：S180 / S181
页数：2
相关论文
共 50 条
  • [31] Cost-Effectiveness of Adding Androgen Deprivation Therapy to Radiation Therapy for Men with Advanced Prostate Cancer from a US Payer's Perspective
    Nguyen, Chi
    Lairson, David R.
    Swartz, Michael D.
    Du, Xianglin L.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (02): : 225 - 234
  • [32] Cost-effectiveness of Prostate Health Index for prostate cancer detection
    Nichol, Michael B.
    Wu, Joanne
    Huang, Joice
    Denham, Dwight
    Frencher, Stanley K.
    Jacobsen, Steven J.
    BJU INTERNATIONAL, 2012, 110 (03) : 353 - 362
  • [33] DIFFERENTIAL TREATMENT RESPONSE OF PROSTATE AND METASTATIC LESIONS IN PATIENTS WITH NEWLY DIAGNOSED METASTATIC PROSTATE CANCER
    Esen, Baris
    Seymen, Hulya
    Falay, Okan
    Tarim, Kayhan
    Kilic, Mert
    Bavbek, Sevil
    Kordan, Yakup
    Tilki, Derya
    Esen, Tarik
    Demirkol, Mehmet Onur
    JOURNAL OF UROLOGY, 2023, 209 : E490 - E490
  • [34] Effectiveness and cost-effectiveness of prognostic markers in prostate cancer
    Calvert, NW
    Morgan, AB
    Catto, JWF
    Hamdy, FC
    Akehurst, RL
    Mouncey, P
    Paisley, S
    BRITISH JOURNAL OF CANCER, 2003, 88 (01) : 31 - 35
  • [35] Effectiveness and cost-effectiveness of prognostic markers in prostate cancer
    N W Calvert
    A B Morgan
    J W F Catto
    F C Hamdy
    R L Akehurst
    P Mouncey
    S Paisley
    British Journal of Cancer, 2003, 88 : 31 - 35
  • [36] Cost-effectiveness analysis of LHRH agonists in the treatment of metastatic prostate cancer in Italy
    Iannazzo, S.
    Pradelli, L.
    Carsi, M.
    Perachino, M.
    VALUE IN HEALTH, 2011, 14 (01) : 80 - 89
  • [37] Decision analytic cost-effectiveness model to compare prostate cryotherapy to androgen deprivation therapy for treatment of radiation recurrent prostate cancer
    Boyd, Kathleen A.
    Jones, Rob J.
    Paul, Jim
    Birrell, Fiona
    Briggs, Andrew H.
    Leung, Hing Y.
    BMJ OPEN, 2015, 5 (10):
  • [38] Cost-Effectiveness of Fracture Prevention in Men Who Receive Androgen Deprivation Therapy for Localized Prostate Cancer
    Ito, Kouta
    Elkin, Elena B.
    Girotra, Monica
    Morris, Michael J.
    ANNALS OF INTERNAL MEDICINE, 2010, 152 (10) : 621 - +
  • [39] Cost-effectiveness of prostate cancer chemoprevention among high-risk men
    Zeliadt, Steven B.
    Ramsey, Scott D.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2010, 10 (05) : 505 - 508
  • [40] Prostate Cancer Cost-effectiveness of Prostate Cancer Diagnostics: Exploring new Innovations
    Kunde, Katharina
    GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2022, 27 (02): : 68 - 69
12345